Down-regulation of MET, the receptor for hepatocyte growth factor
Authors:
- Dean E HammondDHDean E Hammond
- Sylvie UrbéSUSylvie Urbé
- George F Vande WoudeGWGeorge F Vande Woude
- Michael J ClagueMCMichael J Clague
- 17 May 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (22) , 2761-2770
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 36 references indexed in Scilit:
- UBIQUITIN AND THE CONTROL OF PROTEIN FATE IN THE SECRETORY AND ENDOCYTIC PATHWAYSAnnual Review of Cell and Developmental Biology, 1998
- Control of EGF Receptor Signaling by Clathrin-Mediated EndocytosisScience, 1996
- Ligand-Activated Platelet-Derived Growth Factor β-Receptor Is Degraded through Proteasome-Dependent Proteolytic PathwayBiochemical and Biophysical Research Communications, 1995
- Degradation Process of Ligand-stimulated Platelet-derived Growth Factor β -Receptor Involves Ubiquitin-Proteasome Proteolytic PathwayJournal of Biological Chemistry, 1995
- Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene productBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- Mutations in human dynamin block an intermediate stage in coated vesicle formationJournal of Cell Biology, 1993
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Ligand-Induced Transformation by a Noninternalizing Epidermal Growth Factor ReceptorScience, 1990
- A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived ProteinScience, 1989
- Molecular cloning of a new transforming gene from a chemically transformed human cell lineNature, 1984